Is PepGen Inc. (PEPG) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 4.8% / 30% | 30.8% / 30% | 0.0% / 30% | N/A | ✗ NOT HALAL |
| DJIM | 4.8% / 33% | 30.8% / 33% | 0.0% / 33% | N/A | ✓ HALAL |
| MSCI | 12.4% / 33% | 79.7% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| S&P | 4.8% / 33% | 30.8% / 33% | 0.0% / 33% | N/A | ✓ HALAL |
| FTSE | 12.4% / 33% | 79.7% / 33% | 0.0% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -67.4% | |
| Return on Assets (ROA) | -36.0% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$82M |
| Free Cash Flow | -$82M |
| Total Debt | $17M |
| Debt-to-Equity | 11.5 |
| Current Ratio | 11.9 |
| Total Assets | $174M |
Price & Trading
| Last Close | $4.89 |
| 50-Day MA | $5.59 |
| 200-Day MA | $3.95 |
| Avg Volume | 719K |
| Beta | 1.9 |
|
52-Week Range
$0.88
| |
About PepGen Inc. (PEPG)
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is PepGen Inc. (PEPG) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), PepGen Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is PepGen Inc.'s debt ratio?
PepGen Inc.'s debt ratio is 4.8% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 12.4%.
What are PepGen Inc.'s key financial metrics?
PepGen Inc. has a market capitalization of $312M. Return on equity stands at -67.4%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.